To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RP2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
115 supporting clones for gene RP2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA854706 placenta .a 1 to 578 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
NM_006915.2   .a 5 to 3835 1 to 3831 exact RefSeq,   3831/3831
(100 %)
0 diff
(100 %id)
DA211161 brain .a 6 to 529 2 to 526   capped   525/525
(100 %)
2 diff
(99.7 %id)
DA034053   .a 22 to 546 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DB233678 trachea .a 23 to 616 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DB241265 trachea .a 24 to 611 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
AJ007590 brain .a 33 to 3835 12 to 3813 N168D     3802/3813
(99 %)
12 diff
(99.7 %id)
CX762053 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 33 to 763 35 to 765     Submitted on the opposite strand 731/765
(95 %)
7 diff
(99.1 %id)
DA677472   .a 37 to 623 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DB132838 thymus .a 37 to 583 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BI461048 testis .a 44 to 654 1 to 610       610/610
(100 %)
6 diff
(99.1 %id)
DB471821 hippocampus .a 48 to 551 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
AW500788 lymph .a 51 to 441 16 to 407       392/407
(96 %)
9 diff
(97.8 %id)
TI_154155102   .a 51 to 591 86 to 626       541/551
(98 %)
18 diff
(96.8 %id)
BP321274 placenta .a 53 to 636 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP351621   .a 53 to 642 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
DA128933 cerebellum .a 54 to 582 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
CF995062 Human Placenta, placenta .a 54 to 877 29 to 859       831/899
(92 %)
19 diff
(97.9 %id)
DA851129 placenta .a 54 to 611 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA098468 cerebellum .a 55 to 600 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
AW503300 lymph .a 59 to 500 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
DA809160 brain .a 60 to 605 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
TI_154159198   .a 65 to 739 88 to 759       672/674
(99 %)
18 diff
(97.4 %id)
BC043348 Uterus, leiomyosarcoma .a 83 to 3831 1 to 3749 exact tiling clone, available from MGC, AAA   3749/3749
(100 %)
1 diff
(100.0 %id)
BM542799 leiomyosarcoma, uterus .a 83 to 1023 13 to 957       945/957
(98 %)
20 diff
(98.0 %id)
BC053530 Eye, retinoblastoma .a 85 to 3831 1 to 3747 exact available from MGC, AAA   3747/3747
(100 %)
1 diff
(100.0 %id)
AL121304 melanoma (MeWo cell line) .a 97 to 504 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
DA858618 placenta .a 110 to 710 2 to 603   capped   602/602
(100 %)
1 diff
(99.9 %id)
DA100728 cerebellum .a 135 to 695 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA670858   .a 135 to 724 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BM147343 leukopheresis .a 135 to 623 1 to 489       489/490
(99 %)
2 diff
(99.6 %id)
DN994139 brain, whole brain .a 136 to 724 1 to 587       587/587
(100 %)
7 diff
(98.9 %id)
DA670506   .a 137 to 724 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA672796   .a 137 to 731 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA677366   .a 137 to 663 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA990509 synovial membrane tissue from rheumatioidarthritis .a 137 to 684 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BP222632   .a 138 to 719 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB231715 trachea .a 139 to 704 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
BM153082 leukopheresis .a 141 to 600 1 to 462       462/462
(100 %)
29 diff
(93.8 %id)
AL543198 placenta, Placenta Cot 25-normalized .a 152 to 1159 1 to 1010       1010/1010
(100 %)
2 diff
(99.9 %id)
BI093391 cervix .a 152 to 908 1 to 757       757/803
(94 %)
18 diff
(97.8 %id)
DA674613   .a 160 to 718 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AK312555 tongue, tumor tissue .a 171 to 1246 1 to 1076 L93P     1076/1076
(100 %)
2 diff
(99.9 %id)
DA459883 tongue, tumor tissue .a 172 to 727 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
TI_1948212039   .a 193 to 750 133 to 691   fully sequenced,   559/691
(80 %)
6 diff
(99.2 %id)
TI_1948212180   .a 193 to 700 133 to 644   fully sequenced,   512/644
(79 %)
6 diff
(99.1 %id)
TI_1948212320   .a 193 to 668 129 to 611   fully sequenced,   483/611
(79 %)
6 diff
(99.1 %id)
TI_1948212458   .a 193 to 811 131 to 753   fully sequenced,   623/753
(82 %)
6 diff
(99.3 %id)
EL734439 mixed .a 194 to 859 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
BM922508 leukocyte .a 196 to 1311 9 to 1137       1129/1138
(99 %)
54 diff
(95.3 %id)
CN354598 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 216 to 817 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BE927200 colon .a 474 to 948 477 to 7       471/477
(98 %)
0 diff
(100 %id)
BU619730 Cell Line, Chondrosarcoma .a 591 to 1390 812 to 19   AAA   794/794
(100 %)
9 diff
(98.9 %id)
TI_1948212321   .a 638 to 1245 733 to 122   fully sequenced,   612/733
(83 %)
0 diff
(100 %id)
TI_1948212181   .a 670 to 1245 689 to 113   fully sequenced,   577/689
(83 %)
4 diff
(99.5 %id)
BI094263 cervix .a 691 to 1335 1 to 655       655/888
(73 %)
21 diff
(97.7 %id)
TI_1948212040   .a 720 to 1245 657 to 123   fully sequenced,   535/657
(81 %)
0 diff
(100 %id)
AW963188   .a 722 to 1287 1 to 567       567/570
(99 %)
19 diff
(96.7 %id)
TI_1948212459   .a 781 to 1245 585 to 111   fully sequenced,   475/585
(81 %)
16 diff
(97.3 %id)
BU181281 large cell carcinoma, lung .a 943 to 1770 1 to 834       834/843
(98 %)
11 diff
(98.7 %id)
BF541399 hypernephroma, Kidney .a 1155 to 1777 1 to 630       630/729
(86 %)
30 diff
(95.9 %id)
BG185540   .a 1182 to 1395 30 to 245   AAA   216/245
(88 %)
6 diff
(97.6 %id)
DB159212 thymus .a 1229 to 1793 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BE541951 cervix .a 1303 to 1962 1 to 660       660/896
(73 %)
37 diff
(95.9 %id)
DA463741   .a 1370 to 1920 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BU175588 embryonal carcinoma, cell line, testis .a 1377 to 2259 1 to 886       886/886
(100 %)
20 diff
(97.8 %id)
DA831428 placenta .a 1487 to 2275 2 to 795   capped   794/840
(94 %)
11 diff
(98.7 %id)
CD644614 Embryonic Stem cells .a 1577 to 2316 6 to 740       735/820
(89 %)
16 diff
(98.1 %id)
BI090328 cervix .a 1582 to 2322 1 to 754       754/755
(99 %)
29 diff
(96.2 %id)
BG251177 adenocarcinoma, cell line, Liver .a 1773 to 2467 1 to 695       695/698
(99 %)
7 diff
(99.0 %id)
DA140444 alzheimer cortex .a 1809 to 2287 2 to 481   capped   480/481
(99 %)
4 diff
(99.2 %id)
BG772118 testis .a 2027 to 2814 1 to 782       782/870
(89 %)
29 diff
(96.7 %id)
BX106200 liver and spleen .a 2122 to 2867 1 to 746       746/746
(100 %)
0 diff
(100 %id)
W00899 liver and spleen .a 2160 to 2622 1 to 471       471/471
(100 %)
13 diff
(97.3 %id)
W00928 liver and spleen .a 2160 to 2519 1 to 368       368/430
(85 %)
9 diff
(98.0 %id)
BU616754 Cell Line, Chondrosarcoma .a 2359 to 2997 714 to 76   AAA   639/696
(91 %)
0 diff
(100 %id)
AL049366 uterus .a 2419 to 3831 1 to 1413   available from DKFZ, AAA   1413/1413
(100 %)
0 diff
(100 %id)
AL047090 uterus .a 2420 to 2818 1 to 399       399/400
(99 %)
1 diff
(99.8 %id)
AL079912 uterus .a 2420 to 2818 1 to 399       399/400
(99 %)
1 diff
(99.8 %id)
CA308210 Alveolar Macrophage, lung .a 2464 to 3171 726 to 19   AAA   708/708
(100 %)
4 diff
(99.5 %id)
BG290868 bladder, transitional cell papilloma, cell line .a 2471 to 3127 1 to 654       654/848
(77 %)
15 diff
(98.3 %id)
BG677369 skin, squamous cell carcinoma .a 2534 to 3083 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
DA734492   .a 2546 to 3214 2 to 670   capped   669/669
(100 %)
7 diff
(99.0 %id)
BG391236 embryonal carcinoma, cell line, testis .a 2549 to 3392 1 to 834       834/838
(99 %)
29 diff
(96.6 %id)
BF176063 blood .a 2737 to 2937 1 to 201       201/201
(100 %)
6 diff
(97.1 %id)
AL569825 placenta, Placenta Cot 25-normalized .a 2833 to 3801 964 to 1       964/1005
(95 %)
15 diff
(98.6 %id)
BP419475 small intestine .a 2918 to 3418 1 to 502     Submitted on the opposite strand 502/502
(100 %)
1 diff
(99.9 %id)
CF454441 peripheral nervous system .a 3073 to 3800 15 to 742       728/742
(98 %)
6 diff
(99.2 %id)
CA748579 Alveolar Macrophage, lung .a 3077 to 3831 771 to 19   AAA   753/753
(100 %)
4 diff
(99.5 %id)
BQ774111 Bone, Human Chondrosarcoma Cell Line .a 3117 to 3794 1 to 678     Submitted on the opposite strand 678/691
(98 %)
6 diff
(99.2 %id)
CA307411 Alveolar Macrophage, lung .a 3125 to 3831 725 to 19   AAA   707/707
(100 %)
0 diff
(100 %id)
AA742433 pooled germ cell tumors .a 3151 to 3833 682 to 2       681/732
(93 %)
0 diff
(100 %id)
BQ019722 Chondrosarcoma, Left Pubic Bone .a 3169 to 3831 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
TI_154134110   .a 3182 to 3831 765 to 110   AAA   656/1146
(57 %)
15 diff
(98.7 %id)
DB377090 placenta .a 3259 to 3831 568 to 2       567/591
(95 %)
0 diff
(100 %id)
DB366574   .a 3291 to 3831 545 to 1       545/546
(99 %)
7 diff
(98.8 %id)
AW576370 lymph .a 3296 to 3831 553 to 18   AAA   536/537
(99 %)
1 diff
(99.9 %id)
AW674269 cervix .a 3375 to 3832 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW080552 colon, moderately differentiated adenocarcinoma .a 3379 to 3833 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
BI020123 marrow .a 3386 to 3504 1 to 119       119/119
(100 %)
0 diff
(100 %id)
N35921 melanocyte .a 3390 to 3831 448 to 1       448/448
(100 %)
7 diff
(98.5 %id)
AW020082 cochlea, ear .a 3397 to 3755 1 to 359       359/359
(100 %)
4 diff
(98.9 %id)
N70013 liver and spleen .a 3401 to 3825 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AA885767 pooled germ cell tumors .a 3419 to 3830 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AI440157 lymph node, lymphoma, follicular mixed small and largecell .a 3424 to 3844 422 to 2       421/422
(99 %)
0 diff
(100 %id)
AI610511 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3444 to 3835 394 to 3       392/394
(99 %)
0 diff
(100 %id)
AI433058 adenocarcinoma, Pancreas .a 3448 to 3835 393 to 6       388/393
(98 %)
0 diff
(100 %id)
AW243690 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3465 to 3831 379 to 13   AAA   367/367
(100 %)
1 diff
(99.8 %id)
AW473707 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3482 to 3829 351 to 4       348/351
(99 %)
0 diff
(100 %id)
FN080376 breast carcinoma .a 3489 to 3565 76 to 1     Submitted on the opposite strand 76/79
(96 %)
1 diff
(98.8 %id)
N70096 liver and spleen .a 3496 to 3833 341 to 1       341/359
(94 %)
8 diff
(97.8 %id)
BM149525 leukopheresis .a 3505 to 3835 344 to 13       332/344
(96 %)
0 diff
(100 %id)
AI824459 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3511 to 3832 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AA555240 normal prostatic epithelial cells, Prostate .a 3537 to 3832 9 to 304       296/304
(97 %)
6 diff
(98.1 %id)
DA377481 thalamus .b 1 to 595 2 to 596 exact tiling clone, capped   595/595
(100 %)
0 diff
(100 %id)
DA632525 Kidney .c-u 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BC027851 Lung, Spleen, fetal, pooled .c-u 14 to 1671 1 to 1658 exact tiling clone, available from MGC, AAA   1658/1658
(100 %)
0 diff
(100 %id)
BI771880 pooled lung and spleen .c-u 14 to 907 1 to 903   available from MGC,   903/904
(99 %)
25 diff
(97.3 %id)
TI_57179616   .c-u 14 to 907 35 to 937       903/938
(96 %)
25 diff
(97.4 %id)
AV695023 hepatocellular carcinoma .c-u 310 to 725 1 to 410       410/410
(100 %)
9 diff
(97.9 %id)
AV698980 hepatocellular carcinoma .c-u 310 to 948 1 to 629       629/653
(96 %)
33 diff
(95.0 %id)
AV697985 hepatocellular carcinoma .c-u 310 to 972 1 to 656   fully sequenced,   656/656
(100 %)
19 diff
(97.2 %id)
AV685932 hepatocellular carcinoma .c-u 311 to 972 1 to 659       659/662
(99 %)
21 diff
(96.9 %id)
AV687053 hepatocellular carcinoma .c-u 325 to 973 1 to 647   fully sequenced,   647/647
(100 %)
30 diff
(95.4 %id)
CR736555 pooled .c-u 484 to 949 1 to 467       467/467
(100 %)
3 diff
(99.4 %id)
AV700866 hepatocellular carcinoma .c-u 953 to 1651 696 to 1       696/698
(99 %)
16 diff
(97.8 %id)
AV700869 hepatocellular carcinoma .c-u 958 to 1651 696 to 1       696/696
(100 %)
33 diff
(95.3 %id)
AV700021 hepatocellular carcinoma .c-u 962 to 1659 698 to 1   fully sequenced,   698/698
(100 %)
46 diff
(93.5 %id)
AV699301 hepatocellular carcinoma .c-u 966 to 1650 687 to 1   fully sequenced,   687/687
(100 %)
47 diff
(93.2 %id)
AV700129 hepatocellular carcinoma .c-u 972 to 1656 686 to 1       686/690
(99 %)
28 diff
(96.0 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI